![]() |
|
|
Vol. 297, Issue 3, 1082-1087, June 2001
Department of Biomedical Sciences, Section of Pharmacology (C.B., S.G., M.M.C., G.F., C.M., A.B.) and Section of General Pathology (A.T., A.B.), University of Modena and Reggio Emilia, Modena, Italy; Department of Morphological Sciences and Forensic Medicine, University of Modena and Reggio Emilia, Modena, Italy (D.Z.); and Department of Human Pathology, University of Pavia, Pavia, Italy (A.R.B)
| |
Abstract |
|---|
|
|
|---|
The influence of the melanocortin peptide ACTH-(1-24)
(adrenocorticotropin) on the consequences of short-term coronary
ischemia (5 min) followed by reperfusion, and the effect of the
long-acting melanocortin
[Nle4,D-Phe7]
-melanocyte-stimulating
hormone (NDP-MSH) on the damage induced by a permanent coronary
occlusion, were investigated in anesthetized rats. Ischemia was
produced by ligature of the left anterior descending coronary artery.
Reperfusion-induced arrhythmias [ventricular tachycardia (VT),
ventricular fibrillation (VF)] and survival rate within the 5 min
following reperfusion, blood levels of free radicals detected 2 min
after reperfusion by electron spin resonance spectrometry, and
amount of healthy myocardial tissue, measured 72 h after permanent
coronary occlusion on immunohistologically stained serial sections,
were evaluated. Postischemic reperfusion induced VT in all
saline-treated rats, and VF and death in a high percentage of animals
(87%). In rats treated i.v. (2.5 min after coronary occlusion) with
ACTH-(1-24) (0.16-0.48 mg/kg) there was a significantly dose-dependent
reduction in the incidence of arrhythmias and lethality.
Ischemia/reperfusion caused a large increase in free radical blood
levels; treatment with ACTH-(1-24) (0.48 mg/kg i.v.) almost completely
prevented this increase. In rats subjected to permanent coronary
occlusion, the amount of healthy myocardial tissue was much reduced in
saline-treated rats, while in rats treated s.c. with NDP-MSH (0.27 mg/kg every 12 h) it was significantly higher. The present data
demonstrate, for the first time, an unforeseen property of melanocortin
peptides, i.e., their ability to significantly reduce both heart
ischemia/reperfusion injury and size of the ischemic area induced by
permanent coronary occlusion.
| |
Introduction |
|---|
|
|
|---|
Reperfusion
of myocardium subjected to a transient period of ischemia rapidly
induces severe ventricular arrhythmias (Manning and Hearse, 1984
). The
main pathogenetic factors of such reperfusion-induced sudden
arrhythmogenesis include a burst of oxygen free radical discharge
(Woodward and Zakaria, 1985
), a Ca2+ overload in
the intracellular space (Manning and Hearse, 1984
; Kihara and Morgan,
1991
), and the rapid washout of extracellular protons (Avkiran and
Ibuki, 1992
). Moreover, myocardial ischemia is associated with the
release of massive amounts of noradrenaline within the ischemic
myocardium (Schömig et al., 1984
, 1987
; Obata et al., 1994
). This
results in excess sympathetic stimulation that not only contributes to
the development of ventricular arrhythmias (Akiyama et al., 1991
) but
also accelerates the development of irreversible cellular damage (Rona,
1985
). Following a sufficiently long period of ischemia, reperfusion
can enhance the damage to the myocardium with an increase in swelling
of the fibers, possible disruption of the sarcolemma, activation of
degradative enzymes (such as proteases, endonucleases, and
phospholipases), cell death, and enlargement of the necrotic area (Van
der Vusse et al., 1994
). A large body of evidence indicates that an
inflammatory response also plays an important role in the
pathophysiology of myocardial ischemia-reperfusion injury (Engler et
al., 1986
; Lucchesi, 1990
).
In both animals and humans, several melanocortin peptides
[ACTH-(1-24),
-melanocyte-stimulating hormone, and other fragments or fragment analogs of the ACTH molecule] have a prompt and sustained resuscitating effect in conditions of severe tissue hypoxia, either due
to hypoperfusion (hemorrhage-induced hypovolemic shock, hypovolemic shock produced through the graded occlusion of the inferior vena cava,
cardiogenic shock, splanchnic artery occlusion shock) (Bertolini et
al., 1986
, 1987
; Noera et al., 1989
, 1991
; Pinelli et al., 1989
;
Bertolini, 1995
; Ludbrook and Ventura, 1995
; Squadrito et al., 1999
) or
to prolonged respiratory arrest (Guarini et al., 1997a
). We have
previously shown that the hemorrhagic shock reversal produced by the
melanocortin peptide ACTH-(1-24), as well as its resuscitating effect
in a condition of prolonged respiratory arrest, are associated with a
substantial reduction in circulating free radicals. Also nitric oxide
level is decreased, by a direct inhibition of inducible nitric-oxide
synthase induction at the level of mRNA transcription. Free radicals,
including nitric oxide, are massively overproduced in such conditions,
suggesting that melanocortins prevent their generation during the phase
of recovery, characterized by blood mobilization and subsequent tissue
reperfusion (Guarini et al., 1996
, 1997b
, 1998
; Altavilla et al.,
2000
). Finally, accumulating data indicate that melanocortins have a
peculiar anti-inflammatory activity (for reviews, see Lipton and
Catania, 1997
; Wikberg, 1999
). On the whole, the above-mentioned
knowledge prompted us to study the possible effect of melanocortins on
the consequences of short-term coronary ischemia followed by
reperfusion, and on the damage induced by a permanent coronary occlusion.
| |
Materials and Methods |
|---|
|
|
|---|
Animals and Surgery.
Adult Wistar rats of either sex,
weighing 280 to 320 g, were used. They were kept in air
conditioned colony rooms (temperature 21 ± 1°C; humidity 60%)
on a natural light/dark cycle, with food in pellets and tap water
available ad libitum. Housing conditions and experimental procedures
were in strict accordance with the European Community regulations on
the use and care of animals for scientific purposes. The animals were
acclimatized to our housing conditions for at least 1 week before use.
Rats were anesthetized with urethane (1.25 g/kg i.p.) and fixed in the
supine position on a heated operating platform, so to maintain rectal
temperature at 37.5°C. Under clean dissection, indwelling catheters
were inserted into a common carotid artery and into a femoral vein. The
arterial catheter was connected to a Statham P23 Db transducer for the recording of arterial pressure on a polygraph (Mortara-Rangoni, Bologna, Italy); the venous catheter was used for drug administration. Rats were given i.v. heparin (600 IU/kg). After cannulation of the
trachea, the animals were ventilated with room air by means of a
respirator for small rodents with a stroke volume of approximately 20 ml/kg and a rate of 70 strokes/min. These ventilation parameters maintained arterial pO2,
pCO2, and pH within the normal range. The lead II
ECG was recorded by means of needle electrodes placed s.c. on the
limbs. The chest was then opened by a left thoracotomy, the pericardium
incised, and the heart gently exteriorized by pressure on the abdomen
(Selye et al., 1960
). A loose loop [5/0 braided silk suture attached
to a 10-mm micropoint reverse cutting needle (Ethicon K-890)] was
placed around the left anterior descending coronary artery, close to
its origin. A polyethylene tube was threaded over the suture and the
heart was replaced in the chest cavity with the ligature ends
exteriorized, and any animal in which this procedure itself produced
dysrhythmias or a sustained fall in mean arterial pressure to less than
60 mm Hg was discarded from the study at this point. After an
equilibration period of 15 min the ligature was tied. In a group of
animals, after a 5-min period of coronary occlusion, reperfusion was
obtained by cutting the suture according to the device of Manning et
al. (1989)
, and the animals were then monitored for a further 5 min,
recording lethality and occurrence of dysrhythmias. In another group of animals, the left coronary artery was permanently ligated, and after
the heart had been replaced in the chest cavity, the surgical incision
of the chest wall was sutured. Sham-operated animals underwent all the
previously described procedures, apart from the fact that the suture
passing around the left coronary artery was not tied.
Drugs and Treatments. ACTH-(1-24), NDP-MSH, lidocaine hydrochloride, and heparin sodium were purchased from Sigma (St. Louis, MO); Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) from Aldrich (Milwaukee, WI), and urethane from Fluka AG (Buchs, Switzerland). All drugs were freshly dissolved in saline immediately before use. The i.v., s.c., and i.p. injections were in a volume of 1 ml/kg.
In the ischemia/reperfusion experiments, lidocaine, used as reference antiarrhythmic compound, was i.v. injected at the dose of 5 mg/kg, either 10 min before coronary artery ligature (dose and time chosen on the basis of previous experiments performed in our laboratory using the same strain of rats and the same experimental procedure) (Guarini et al., 1995Measurement of Arrhythmias.
The ECG was continuously
monitored and recorded up to the 5th min after reperfusion. Chart speed
was set at 50 mm/s a few seconds before reperfusion so as to obtain a
permanent high-speed recording of the changes in the ECG during early
reperfusion. The ECG was retrospectively analyzed, in a blinded manner,
for the incidence of VT and VF. All analyses were carried out in
accordance with the Lambeth Conventions (Walker et al., 1988
). VT was
defined as four or more consecutive premature beats of ventricular
origin, and VF was defined as a signal in which individual QRS
deflections could no longer be distinguished from one another and for
which the rate could not be determined.
Histology. The rats that were subjected to permanent occlusion of the left coronary artery, and still surviving 72 h after artery ligature, had their hearts removed under urethane anesthesia, washed in isotonic saline, and fixed in 10% neutral buffered formalin for 24 to 48 h. The hearts were then cut from apex to base in slices of 2.5 mm in thickness, according to the step section technique. Histological and histochemical routine procedures were applied to process the heart slices. They were embedded in paraffin blocks, sectioned (5-6 µm in thickness), and collected on glass slides coated with aminoalkylsilane (Dako, Glostrup, Denmark).
Morphological features of myocardial tissue were studied after H&E staining of sections. Evaluations of acid glycosaminoglycan and glycoprotein content of the myocardium were performed after Alcian blue (pH 2.5) and periodic acid Schiff histochemical staining of sections (all reagents were from Fluka AG). Evaluations of the healthy myocardial tissue and the induced programmed death of cells (apoptosis) were, respectively, performed after anti-actin (Fu et al., 1993Blood Sampling, Extraction of Radical Species, and ESR Spectra
Determination.
A technique modified from Tortolani et al. (1993)
was used to avoid the injection of the spin-trapping agent in vivo.
Each animal had 3 to 4 ml of whole blood rapidly withdrawn via the arterial catheter into a syringe containing 2 ml of a 0.1 M solution of
-phenyl-N-tert-butylnitrone (PBN; Sigma) in isotonic
saline. Each animal served for a single sample. The samples were
immediately centrifuged (1680g for 10 min) and the
plasma/PBN supernatant was added to 12 ml of 2:1 (v/v)
chloroform/methanol for radical extraction. The chloroform layer was
separated, dried under nitrogen flow, the resulting pellet was
resuspended in 250 µl of chloroform, and the ESR spectrum was taken.
ESR spectra were recorded at room temperature using a Bruker 300 ESR
spectrometer (Bruker Spectrospin, Karlsruhe, Germany). Typical
instrumental settings were as follows: microwave power, 20 mW;
modulation amplitude, 0.1 mT; field width, 10 mT; and microwave
frequency, 9.14 GHz. The ESR peak height of the central absorption was
measured and expressed in arbitrary units (a.u.), as a direct function
of adduct concentration; for statistical analysis, the values (a.u.)
were normalized to a fixed sample volume of 1 ml of whole blood.
Statistics. Gaussian-distributed variables were expressed as mean ± S.E. and analyzed for statistical significance by Student's t test for unpaired data, or by means of ANOVA followed by Student-Newman-Keuls test. Binomially distributed variables, such as the incidence of VT, VF, or lethality were compared using Fisher's exact probability test. A value of P < 0.05 was considered significant.
Animals Ethics. Experimental procedures were carried out in accordance with the guidelines of the European Community, local laws, and policies (D.L.vo 116/92).
| |
Results |
|---|
|
|
|---|
Effect of Melanocortins on Ischemia/Reperfusion-Induced Myocardial
Injury.
As shown in Table 1, in
control (saline-treated) rats, coronary reperfusion following 5-min
occlusion caused the abrupt (within a few seconds) occurrence of severe
ventricular arrhythmias (paroxysmal VT in all rats; VF in 13 of 15 rats), with death of 13 of 15 rats within the first 5 min following
reperfusion. The i.v. injection of ACTH-(1-24) 2.5 min before
reperfusion (i.e., 2.5 min after coronary occlusion) dose dependently
reduced the incidence of arrhythmias and the lethality: survival
(within the first 5 min following reperfusion) was 100% starting from
the dose of 0.32 mg/kg, and no episode of VF occurred with the dose of
0.48 mg/kg. Lidocaine, i.v. injected at the dose of 5 mg/kg, and used
as reference antiarrhythmic compound, was almost as effective as the
highest dose of ACTH-(1-24) only when administered 10 min before
coronary ligature (VT in four of eight, VF in zero of eight, and
survival in 100% of rats; data not shown), and less effective when
administered 2.5 min before reperfusion (Table 1). On the other hand,
the antioxidant vitamin E analog Trolox, administered for comparison at
a dose (0.041 mg/kg i.v.) equimolar (162 nmol/kg) to 0.48 mg/kg ACTH-(1-24), was ineffective (Table 1).
|
Histological Evaluation of Melanocortin Effects on Myocardial
Tissue after a Permanent Coronary Artery Occlusion.
The amount of
the healthy myocardial tissue (Fu et al., 1993
), which was measured
72 h after coronary ligature on immunohistologically stained
serial sections by means of an image analyzing computer, was much
reduced in saline-treated rats (24.81 ± 1.92; n = 8), as shown in Fig. 1. At the
histological examination (Fig. 2A) the
ischemic tissue had a transmural appearance extending from endocardium
to epicardium. Subendocardial tissue often appeared involved, as a
circumferential necrosis. Ischemic areas showed an increase of acid
glycosaminoglycan and a decrease of glycoprotein content. A remarkable
inflammatory cell accumulation (polymorphonuclear leukocytes and
monocytes) was found inside the ischemic tissue. The expression of the
cytoplasm apoptotic body (Olivetti et al., 1997
) was very high in the
injured tissue of saline-treated rats (Fig. 2C).
|
|
Effect of Melanocortins on Free Radical Levels in the Blood of Rats
Subjected to Heart Ischemia/Reperfusion.
As shown in Fig.
3, the heart ischemia/reperfusion injury
caused a large increase in the blood levels of free radicals (measured using an ex vivo spin-trapping technique) (basal, preischemia level:
62 ± 7 × 102 a.u./ml whole blood; 2 min after reperfusion: 635 ± 28 × 102
a.u./ml whole blood). The 2-min time period was chosen because, starting from 2.5 to 3 min after reperfusion, control rats begun to
die. Treatment with ACTH-(1-24) almost completely prevented the
ischemia/reperfusion-induced increase in free radical blood levels
(98 ± 9 × 102 a.u./ml whole blood).
Figure 4 depicts representative ESR
spectra. The spectrum obtained during reperfusion in saline-treated
rats is characterized by a well defined three line-signal due to the trapping of circulating free radical species; the signal is not well
defined in ACTH-(1-24)-treated rats. The spectral feature hints to
trapping of multiple radical species (lipids and proteins) arising from
the radical burst.
|
|
| |
Discussion |
|---|
|
|
|---|
Our present results demonstrate that melanocortin peptides are able to exert an effective protection against the outcomes either of a short-term myocardial ischemia followed by reperfusion or of the permanent occlusion of a coronary artery. In the rat model of myocardial ischemia/reperfusion used in our present experiment, which causes a very high incidence of severe ventricular arrhythmias and lethality, ACTH-(1-24) was able to significantly reduce, or to completely prevent, according to the dose, the development of serious arrhythmias, with a consequently high or even complete survival rate. In the rat model of myocardial infarction, produced by the permanent ligature of the left anterior descending coronary artery, the long-acting NDP-MSH {s.c. injected twice daily starting 5 min after coronary artery ligature up to sacrifice (3 days after ligature), at the dose of 0.27 mg/kg [equimolar to 0.48 mg/kg of ACTH-(1-24)]} was able to cause a significant reduction of both infarct size and leukocyte infiltration. The healthy myocardial tissue in the lateral wall of the left ventricle was significantly lower in saline-treated rats (24.81 ± 1.92%, n = 8) than in NDP-MSH-treated rats (69.03 ± 1.39%, n = 8) (P < 0.001). As a consequence, the injured tissue was almost twice as much in saline-treated rats. Moreover, the induced expression of cell apoptotic bodies was very high in saline-treated rats, while it was not detectable in ACTH-(1-24)-treated ones.
Besides being highly effective, melanocortins also were considerably potent in these experimental conditions. Indeed, some signs of the ischemia/reperfusion injury were significantly reduced already by an i.v. dose of 0.16 mg/kg ACTH-(1-24) (significant reduction of lethality), and a virtually complete protection was obtained with an i.v. dose of 0.48 mg/kg (maximum effective dose in our experimental conditions). On the contrary, an equimolar dose of the vitamin E analog Trolox, an extremely efficient antioxidant, had no protective effect. This dose of ACTH-(1-24) also completely prevented the ischemia/reperfusion-induced sharp increase in free radical blood levels.
The pathophysiology of myocardial ischemia/reperfusion injury is
complex and not yet fully understood. However, the role of some factors
is fairly well established. So, the overproduction of free oxygen
radicals must be considered of primary importance in the reperfusion
injury (Manning and Hearse, 1984
; McCord, 1985
; Woodward and Zakaria,
1985
). The main sources of these metabolites are 1) the oxidation of
hypoxanthine to xanthine and on to uric acid by the oxidase form of
xanthine oxidoreductase, and 2) leukocytes accumulating in ischemic and
reperfused tissue. Indeed, a classical inflammatory response takes
place when heart is subjected to ischemia followed by reperfusion
(Lucchesi, 1990
).
The possible mechanisms of the protective effect of melanocortins in
myocardial ischemia and ischemia/reperfusion most likely involve the
capacity of these peptides to inhibit the overproduction of oxygen free
radicals (data that have been confirmed also in the present study) in
conditions of tissue hypoxia (Guarini et al., 1996
, 1998
), and their
quite peculiar anti-inflammatory activity (for reviews, see Lipton and
Catania, 1997
; Wikberg, 1999
).
Already in previous experiments (Guarini et al., 1996
) we produced
evidence suggesting that ACTH-(1-24) prevents the burst of free radical
generation during tissue reperfusion. This has been confirmed also in
the present experimental conditions: the blood levels of free radicals
were 635 ± 28 × 102 a.u./ml 2 min
after reperfusion in saline-treated rats, and 98 ± 9 × 102 a.u./ml in ACTH-(1-24)-treated rats (basal,
preischemia level: 62 ± 7 × 102
a.u./ml). The mechanism by which melanocortins prevent free radical formation cannot be ascribed to a direct radical scavenging activity (Guarini et al., 1996
) both because of their chemical structure (a
peptide is in se a poor radical scavenger) and because of the extremely
low concentrations used. In fact, the vitamin E analog Trolox, an
extremely efficient antioxidant, when used at melanocortin equimolar
concentration, has no protective activity. Thus, the mechanism(s)
responsible of such an effective antioxidant activity of melanocortins
remains elusive; a central nervous system involvement could be
postulated, on the basis of previous data (Guarini et al., 1999
) and of
recent findings (Borovikova et al., 2000
).
On the other hand, melanocortin peptides have been shown to inhibit the
inflammation in many experimental conditions, such as arthritis, brain
inflammation/ischemia, and kidney ischemia (for reviews, see Lipton and
Catania, 1997
; Wikberg, 1999
). The anti-inflammatory effects of
melanocortin peptides are often associated with a reduced production of
proinflammatory cytokines, such as interleukin-1
, interleukin-1
,
interleukin-6, and tumor necrosis factor-
(Luger et al., 1997
;
Lipton et al., 1998
), and with an increased production of the
anti-inflammatory interleukin-10 and of the angiogenic factor
interleukin-8 (Luger et al., 1997
). It is possible that other
mechanisms of action may be involved in this cardioprotective activity
of melanocortins, as is the case for other cardiovascular effects of
these peptides, particularly in shock conditions (Bertolini, 1995
;
Guarini et al., 1999
).
In conclusion, our present data demonstrate for the first time an unforeseen property of melanocortin peptides, i.e., their ability to significantly attenuate the consequences either of myocardial ischemia/reperfusion or of permanent coronary occlusion. It must of course be stressed that these results have been obtained in animal models. However, in our opinion they are rather exciting, both because they may disclose a completely new therapeutic approach to these so frequent and serious pathological conditions, and because melanocortins are practically devoid of acute toxicity (particularly cardiotoxicity, contrary to all available antiarrhythmic drugs).
| |
Footnotes |
|---|
Accepted for publication February 27, 2001.
Received for publication December 27, 2000.
This work was supported in part by grants from Ministero dell'Università e della Ricerca Scientifica e Tecnologica and Consiglio Nazionale delle Ricerche, Roma, Italy.
Send reprint requests to: Prof. Salvatore Guarini, Department of Biomedical Sciences, Section of Pharmacology, University of Modena and Reggio Emilia, via G. Campi 287, 41100 Modena, Italy. E-mail: guarini.salvatore{at}unimo.it
| |
Abbreviations |
|---|
ACTH-(1-24), adrenocorticotropin;
NDP-MSH, [Nle4,D-Phe7]
-melanocyte-stimulating
hormone;
VT, ventricular tachycardia;
VF, ventricular fibrillation;
ESR, electron spin resonance;
PBN,
-phenyl-N-tert-butylnitrone;
a.u., arbitrary units.
| |
References |
|---|
|
|
|---|
-MSH and other ACTH fragments improve cardiovascular function and survival in experimental hemorrhagic shock.
Eur J Pharmacol
130:
19-26[Medline].This article has been cited by other articles:
![]() |
G. Leoni, H. B. Patel, A. L. F. Sampaio, F. N. E. Gavins, J. F. Murray, P. Grieco, S. J. Getting, and M. Perretti Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion FASEB J, December 1, 2008; 22(12): 4228 - 4238. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kang, K. W. McIntyre, K. M. Gillooly, Y. Yang, J. Haycock, S. Roberts, A. Khanna, T. F. Herpin, G. Yu, X. Wu, et al. A selective small molecule agonist of the melanocortin-1 receptor inhibits lipopolysaccharide-induced cytokine accumulation and leukocyte infiltration in mice J. Leukoc. Biol., October 1, 2006; 80(4): 897 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Giuliani, C. Mioni, D. Altavilla, S. Leone, C. Bazzani, L. Minutoli, A. Bitto, M.-M. Cainazzo, H. Marini, D. Zaffe, et al. Both Early and Delayed Treatment with Melanocortin 4 Receptor-Stimulating Melanocortins Produces Neuroprotection in Cerebral Ischemia Endocrinology, March 1, 2006; 147(3): 1126 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Guarini, M. M. Cainazzo, D. Giuliani, C. Mioni, D. Altavilla, H. Marini, A. Bigiani, V. Ghiaroni, M. Passaniti, S. Leone, et al. Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway Cardiovasc Res, August 1, 2004; 63(2): 357 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Catania, S. Gatti, G. Colombo, and J. M. Lipton Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation Pharmacol. Rev., March 1, 2004; 56(1): 1 - 29. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||